Drones to control capacity
July 8, 2021
Lightweight sprayed materials for reinforcing and rehabilitating urban heritage buildings and structures
July 15, 2021inLab FIB is collaborating with the company ABAC Therapeutics (ABAC) to develop a drug discovery platform to identify new antibiotics designed to combat multidrug-resistant bacteria.
ABAC Therapeutics is a company that investigates new antibiotics for certain pathogens and develops treatment solutions against multiantibiotic-resistant bacteria. ABAC uses its own drug discovery platform PasNas to identify new antibiotics designed to combat multidrug-resistant bacteria for patients infected with bacterial pathogens that are highly resistant to antibiotics that leave patients affected with few (or no) treatment options. This new strategy enables the identification of compounds with specific activity and new mechanisms of action that do not harm human bacterial flora and minimise the selection of resistant strains.
inLab FIB is in charge of developing the computer platform that supports the analysis of data from experimental processes.
The project has been developed in two periods: an initial period from July 2018 to January 2019 and an extension of the project from July 2020 until December 2021.
Technology
Topic
You want to know more?
Related Projects
- Neurodegenerative diseases, such as Parkinson's disease, Alzheimer's, and age-related disorders, have been widely studied due to their significant impact on individuals and society. So far, these are incurable and debilitating diseases that lead to progressive degeneration and death of nerve cells, resulting in cognitive and mobility impairments. Tremors, mainly at rest, slowness of movement (bradykinesia), limb rigidity, and issues with gait and balance are typical motor disorders related to Parkinson’s disease. Additionally, due to progressive muscle atrophy, these issues can lead to falls, which in turn result in further complications and risks to quality of life.
- The Biomaterials, Biomechanics, and Tissue Engineering (BBT) Research Group at the Institute for Health Research and Innovation (IRIS) of the Universitat Politècnica de Catalunya – BarcelonaTech (UPC) is leading DYNAMIC, a project aimed at creating multifunctional, stimuli-responsive biomaterials that not only promote bone regeneration but also intelligently and effectively combat bacterial infections.
- 30/09/2024Project Headerrightno-repeat;left top;;auto20px A team from the Centre for Research in Biomedical Engineering (CREB) of the UPC and Sant Joan de Déu has created a new […]
- Barcelona is characterised by a high consumption of bottled water (55% of the population drinks it regularly). The reasons for this behaviour tend to be dissatisfaction with the organoleptic characteristics, perceived health risks and distrust of the quality of tap water.
